What is Bioseal?
Bioseal Inc. is a seasoned surgical supplier with over 35 years of operational experience, dedicated to equipping hospitals with essential medical supplies. The company's specialization encompasses surgical put-ups, single-use instruments, and comprehensive infection control solutions. Key product offerings include the Duraholder Instrument Protection System, BioView Scopes, and customizable procedural trays, catering to the needs of healthcare professionals such as sterile processing managers, operating room managers, and infection control specialists. Bioseal's commitment to stringent quality management and bespoke manufacturing ensures consistent customer satisfaction across the nation.
How much funding has Bioseal raised?
Bioseal has raised a total of $1.3M across 2 funding rounds:
Debt
$350K
Debt
$926K
Debt (2020): $350K with participation from PPP
Debt (2021): $926K led by PPP
What's next for Bioseal?
The recent major strategic investment signals a period of significant growth and potential expansion for Bioseal. This capital infusion is likely to bolster the company's capacity for innovation in surgical instrumentation and infection control technologies. Future initiatives may involve scaling production, enhancing distribution networks, and potentially exploring new market segments within the healthcare industry. The company's focus on quality and custom solutions positions it well to leverage this new backing for sustained development and market leadership.
See full Bioseal company page
